Citation: | GE Yirong, RAO Mei, BI Jing, TAN Sihai, HAN Bin. Relationships of ABC subfamily G member 2 gene polymorphism with therapeutic effect of high-dose methotrexate and renal function injury in children with pediatric acute lymphoblastic leukemia[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 40-44. DOI: 10.7619/jcmp.20215054 |
[1] |
张玉玲, 刘承梅, 曾小青, 等. 甲氨蝶呤目标血药浓度在儿童急性淋巴细胞白血病中的应用[J]. 实用医学杂志, 2018, 34(18): 3093-3096. doi: 10.3969/j.issn.1006-5725.2018.18.026
|
[2] |
姚平立, 何霞, 许晶晶, 等. 亚甲基四氢叶酸还原酶基因多态性与甲氨蝶呤不良反应的Meta分析[J]. 中国新药与临床杂志, 2018, 37(4): 214-222. https://www.cnki.com.cn/Article/CJFDTOTAL-XYYL201804006.htm
|
[3] |
XIE L, GUO W, YANG Y, et al. More severe toxicity of genetic polymorphisms on MTHFR activity in osteosarcoma patients treated with high-dose methotrexate[J]. Oncotarget, 2017, 9(14): 11465-11476. https://pubmed.ncbi.nlm.nih.gov/29545912/
|
[4] |
GERVASINI G, DE MURILLO S G, JIMÉNEZ M, et al. Effect of polymorphisms in transporter genes on dosing, efficacy and toxicity of maintenance therapy in children with acute lymphoblastic leukemia[J]. Gene, 2017, 628: 72-77. doi: 10.1016/j.gene.2017.07.025
|
[5] |
孙锋. 结直肠癌干细胞增殖及侵袭中ABCG2基因的效应[J]. 中国组织工程研究, 2018, 22(13): 2057-2062. doi: 10.3969/j.issn.2095-4344.0503
|
[6] |
ZHAO S, CHEN C, LIU S, et al. CD147 promotes MTX resistance by immune cells through up-regulating ABCG2 expression and function[J]. J Dermatol Sci, 2013, 70(3): 182-189. doi: 10.1016/j.jdermsci.2013.02.005
|
[7] |
高静, 胡绍燕, 卢俊, 等. TEL/AML1基因阳性急性淋巴细胞白血病患儿CCLG-ALL-2008方案疗效分析[J]. 临床儿科杂志, 2017, 35(5): 325-330. doi: 10.3969/j.issn.1000-3606.2017.05.002
|
[8] |
ZHANG H N, HE X L, WANG C, et al. Impact ofSLCO1B1521T >C variant on leucovorin rescue and risk of relapse in childhood acute lymphoblastic leukemia treated with high-dose methotrexate[J]. Pediatr Blood Cancer, 2014, 61(12): 2203-2207. doi: 10.1002/pbc.25191
|
[9] |
LIU S G, GAO C, ZHANG R D, et al. Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia[J]. Oncotarget, 2017, 8(23): 37761-37772. doi: 10.18632/oncotarget.17781
|
[10] |
EL MESALLAMY H O, RASHED W M, HAMDY N M, et al. High-dose methotrexate in Egyptian pediatric acute lymphoblastic leukemia: the impact of ABCG2 C421A genetic polymorphism on plasma levels, what is next[J]. J Cancer Res Clin Oncol, 2014, 140(8): 1359-1365. doi: 10.1007/s00432-014-1670-y
|
[11] |
颜楠, 马晶晶, 夏凡. 大剂量甲氨蝶呤致严重急性肾损伤1例[J]. 中国新药与临床杂志, 2017, 36(3): 173-175. https://www.cnki.com.cn/Article/CJFDTOTAL-XYYL201703011.htm
|
[12] |
徐蕊, 王捷, 李静, 等. 大剂量甲氨蝶呤治疗淋巴系统肿瘤的药物不良反应影响因素分析[J]. 中国临床药理学杂志, 2017, 33(22): 2239-2242. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ201722008.htm
|
[13] |
GERVASINI G, DE MURILLO S G, JIMÉNEZ M, et al. Dihydrofolate reductase genetic polymorphisms affect methotrexate dose requirements in pediatric patients with acute lymphoblastic leukemia on maintenance therapy[J]. J Pediatr Hematol Oncol, 2017, 39(8): 589-595. doi: 10.1097/MPH.0000000000000908
|
[14] |
CHANG Y H, YU M S, WU K H, et al. Effectiveness of parenteral glutamine on methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia[J]. Nutr Cancer, 2017, 69(5): 746-751. doi: 10.1080/01635581.2017.1324995
|
[15] |
唐威, 王松咪, 王雅琴, 等. 复发急性淋巴细胞白血病患儿36例临床特征及预后分析[J]. 中华实用儿科临床杂志, 2018, 33(3): 196-199. doi: 10.3760/cma.j.issn.2095-428X.2018.03.009
|
1. |
张睿,周澜华,张惠,姜砚馨,李一芃,王旭,冯丽莉,张建军. 基于CiteSpace分析国内痤疮患者生命质量的热点和趋势. 中国医药导报. 2023(13): 83-87+117 .
![]() |